Hearne Michael S
- SEC CIK
- 0001759910
No open-market purchases or sales filed in the past year.
Current role at each company
- AUPH Aurinia Pharmaceuticals Inc.Chief Financial Officeras of May 20, 2026
- LJPC La Jolla Pharmaceutical CoChief Financial Officeras of Aug 24, 2022
- ODT Odonate Therapeutics, Inc.Chief Financial Officeras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hearne Michael S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LJPC La Jolla Pharmaceutical Co
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 (view filing)7:07 PM ET | Nov 29-Dec 1 | 2 days | Tang Kevin C and 3 othersDirector, 10% Owner | SSale | −441.3K | $3.93 | −$1.73M | −4.4%9.61M after | 5 lots |
ODT Odonate Therapeutics, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2021 (view filing)4:38 PM ET | Nov 17-19 | 2 days | Tang Kevin C and 3 othersChief Executive Officer | SSale | −2.75M | $2.09 | −$5.73M | −17.7%12.8M after | 8 lots |